Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJacomo, Rafael Henriques
dc.contributor.authorMorais Melo, Raul Antonio
dc.contributor.authorSouto, Fernanda Ribeiro
dc.contributor.authorMattos, Ederson Roberto de
dc.contributor.authorOliveira, Claudia Teresa de
dc.contributor.authorFagundes, Evandro M.
dc.contributor.authorSilva Bittencourt, Henrique Neves da
dc.contributor.authorBittencourt, Rosane Isabel
dc.contributor.authorBortolheiro, Teresa Cristina
dc.contributor.authorPaton, Eduardo J. A.
dc.contributor.authorBendlin, Rodrigo
dc.contributor.authorIsmael, Sebastiao
dc.contributor.authorChauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]
dc.contributor.authorSilva, Dirceu
dc.contributor.authorPagnano, Katia Borgia B.
dc.contributor.authorRibeiro, Raul
dc.contributor.authorRego, Eduardo M.
dc.identifier.citationHaematologica-the Hematology Journal. Pavia: Ferrata Storti Foundation, v. 92, n. 10, p. 1431-1432, 2007.
dc.description.abstractWe report an increased incidence of high relapse risk features in 157 APL Brazilian patients. Out of 134 patients treated with ATRA and anthracyclines, only 91 (67.9%) achieved remission because 43 (32%) died during induction. the death rate during consolidation was 10.5%. Bleeding complications were the most frequent cause of failure (21.6%).en
dc.publisherFerrata Storti Foundation
dc.relation.ispartofHaematologica-the Hematology Journal
dc.rightsAcesso aberto
dc.subjectacute promyelocytic leukemiaen
dc.subjectdeveloping countriesen
dc.titleClinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclinesen
dc.contributor.institutionMed Sch Riberao Preto
dc.contributor.institutionHosp Amaral Carvalho
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionSanta Casa São Paulo
dc.contributor.institutionFundacao Pio XII Barretos
dc.contributor.institutionClin Hematol Riberao Preto
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionSt Jude Childrens Hosp
dc.description.affiliationMed Sch Riberao Preto, Dept Internal Med, Ribeirao Preto, Brazil
dc.description.affiliationHosp Amaral Carvalho, Bone Marrow Transplantat Unit, Jau, Brazil
dc.description.affiliationUniv Fed Minas Gerais, Hematol Serv, Belo Horizonte, MG, Brazil
dc.description.affiliationSanta Casa São Paulo, Hematol Serv, São Paulo, Brazil
dc.description.affiliationFundacao Pio XII Barretos, Barretos, Brazil
dc.description.affiliationClin Hematol Riberao Preto, Ribeirao Preto, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Hematol & Hemotherapy, São Paulo, Brazil
dc.description.affiliationUniv Estadual Campinas, Hemoctr, Campinas, Brazil
dc.description.affiliationSt Jude Childrens Hosp, Internal Outreach Program, Memphis, TN USA
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Hematol & Hemotherapy, São Paulo, Brazil
dc.description.sourceWeb of Science
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000249867100023.pdf193.07 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.